Risk factors for major bleeding among patients with chronic kidney disease treated with acetylsalicylic acid

• Main Authors: Keren Cohen-Hagai (Author), Gil Schwartz Yoskovitz (Author), Meytal Schwartz Yoskovitz (Author), Hadar Haim-Pinhas (Author), Mor Saban (Author), David Pereg (Author), Ori Wand (Author), Ilan Rozenberg (Author), Sydney Benchetrit (Author)
• Format: Book
• Published: Karger Publishers, 2024-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Individuals with chronic kidney disease (CKD) are at increased risk for thrombotic events and bleeding. Acetylsalicylic acid (ASA), an effective antiplatelet agent, is one of the most frequently used medications for both primary and secondary prevention of cardiovascular disease (CVD)....